FdaApplication
NDA 022331
Identifiers
- fda_app_no: NDA022331
Properties
| Property | Value |
|---|---|
| applicant_name | CONCORDIA PHARMACEUTICALS INC |
| application_type | NDA |
| approval_date | 2009-09-30 |
Products (4)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| JENLOGA | CLONIDINE HYDROCHLORIDE | 0.2MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, EXTENDED RELEASE;ORAL |
| JENLOGA | CLONIDINE HYDROCHLORIDE | 0.1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, EXTENDED RELEASE;ORAL |
| KAPVAY | CLONIDINE HYDROCHLORIDE | 0.1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, EXTENDED RELEASE;ORAL |
| KAPVAY | CLONIDINE HYDROCHLORIDE | 0.2MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, EXTENDED RELEASE;ORAL |
4 products